{"id":76467,"date":"2026-10-20T19:48:41","date_gmt":"2026-10-20T19:48:41","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76467"},"modified":"2026-10-20T19:49:43","modified_gmt":"2026-10-20T19:49:43","slug":"us-analyst-updates-october-20th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/","title":{"rendered":"US Analyst Updates \u2014 October 20th, 2026"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\n

Analyst Ratings (USA)<\/strong><\/a><\/h2>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
The overall U.S. analyst outlook remains cautious, with 107 price target reductions significantly outnumbering 51 increases, suggesting growing concerns over stock valuations, earnings expectations, and broader economic uncertainty. While selective opportunities remain in technology, healthcare, and other growth-oriented sectors, analysts appear increasingly focused on downside risks, profitability, and earnings sustainability. The imbalance in target revisions points to a more defensive market environment, with heightened volatility and the potential for further valuation adjustments, although selective upgrades indicate that confidence remains in companies with strong fundamentals and resilient growth prospects.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n

Updates (354)<\/span><\/h3>\n<\/div>\n
\n

Abivax (ABVX)<\/strong> \u2014 Guggenheim reiterated its rating of Buy with a $175.00 price target.<\/p>\n

Absci (ABSI)<\/strong> \u2014 HC Wainwright reiterated its rating of Buy.<\/p>\n

Accel Entertainment (ACEL)<\/strong> \u2014 Truist Financial lowered its price target to $13.00 from $14.00 and maintained its Hold rating.<\/p>\n

Acuity (AYI)<\/strong> \u2014 Morgan Stanley lowered its price target to $380.00 from $410.00 and maintained its Overweight rating.<\/p>\n

ADARx Pharmaceuticals (ADRX)<\/strong> \u2014 JPMorgan initiated at Overweight with a $38.00 price target.<\/p>\n

ADARx Pharmaceuticals (ADRX)<\/strong> \u2014 Morgan Stanley initiated at Overweight with a $32.00 price target.<\/p>\n

ADARx Pharmaceuticals (ADRX)<\/strong> \u2014 TD Cowen initiated at Buy.<\/p>\n

ADARx Pharmaceuticals (ADRX)<\/strong> \u2014 UBS initiated at Buy with a $35.00 price target.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Wedbush reiterated its rating of Outperform with a $600.00 price target.<\/p>\n

Agree Realty (ADC)<\/strong> \u2014 Barclays lowered its price target to $76.00 from $85.00 and maintained its Equal Weight rating.<\/p>\n

Akamai Technologies (AKAM)<\/strong> \u2014 Raymond James upgraded from Outperform to Strong Buy with a $170.00 price target.<\/p>\n

Albemarle (ALB)<\/strong> \u2014 Truist Financial lowered its price target to $185.00 from $225.00 and maintained its Buy rating.<\/p>\n

Alcoa (AA)<\/strong> \u2014 B. Riley Financial lowered its price target to $63.00 from $80.00 and maintained its Buy rating.<\/p>\n

Alcoa (AA)<\/strong> \u2014 DA Davidson set a price target of $62.00.<\/p>\n

Alcoa (AA)<\/strong> \u2014 Freedom Broker lowered its price target to $62.00 from $76.00 and maintained its Buy rating.<\/p>\n

Allegro MicroSystems (ALGM)<\/strong> \u2014 Wells Fargo & Company lowered its price target to $45.00 from $56.00 and maintained its Overweight rating.<\/p>\n

Almonty Industries (ALM)<\/strong> \u2014 Stifel lowered its price target to $21.00 from $25.00 and maintained its Buy rating.<\/p>\n

Alpha Tau Medical (DRTS)<\/strong> \u2014 HC Wainwright reiterated its rating of Buy with a $16.00 price target.<\/p>\n

Alphabet (GOOG)<\/strong> \u2014 BMO Capital Markets reiterated its rating of Outperform with a $480.00 price target.<\/p>\n

Alphabet (GOOGL)<\/strong> \u2014 BMO Capital Markets reiterated its rating of Outperform with a $480.00 price target.<\/p>\n

Amazon.com (AMZN)<\/strong> \u2014 BMO Capital Markets reiterated its rating of Buy.<\/p>\n

Ameren (AEE)<\/strong> \u2014 BMO Capital Markets lowered its price target to $113.00 from $119.00 and maintained its Outperform rating.<\/p>\n

American Airlines Group (AAL)<\/strong> \u2014 Sanford C. Bernstein set a price target of $19.00.<\/p>\n

American Electric Power (AEP)<\/strong> \u2014 BTIG Research upgraded from Neutral to Buy with a $147.00 price target.<\/p>\n

American Tower (AMT)<\/strong> \u2014 Sanford C. Bernstein lowered its price target to $212.00 from $214.00 and maintained its Outperform rating.<\/p>\n

Americold Realty Trust (COLD)<\/strong> \u2014 UBS Group lowered its price target to $14.00 from $16.00 and maintained its Neutral rating.<\/p>\n

Amkor Technology (AMKR)<\/strong> \u2014 B. Riley Financial lowered its price target to $46.00 from $65.00 and maintained its Neutral rating.<\/p>\n

Amplitude (AMPL)<\/strong> \u2014 BTIG Research raised its price target to $17.00 from $13.00 and maintained its Buy rating.<\/p>\n

Amtech Systems (ASYS)<\/strong> \u2014 Lake Street initiated at Buy with a $22.00 price target.<\/p>\n

APA (APA)<\/strong> \u2014 Susquehanna raised its price target to $58.00 from $47.00 and maintained its Positive rating.<\/p>\n

Apple (AAPL)<\/strong> \u2014 Loop Capital downgraded from Buy to Hold with a $330.00 price target.<\/p>\n

Apple (AAPL)<\/strong> \u2014 Moffett Nathanson set a price target of $283.00 with a Neutral rating.<\/p>\n

Applied Materials (AMAT)<\/strong> \u2014 Cantor Fitzgerald reiterated its rating of Outperform.<\/p>\n

argenex (ARGX)<\/strong> \u2014 Royal Bank Of Canada lowered its price target to $1,025.00 from $1,100.00 and maintained its Outperform rating.<\/p>\n

Arhaus (ARHS)<\/strong> \u2014 Piper Sandler upgraded from Neutral to Overweight with a $13.00 price target.<\/p>\n

Arhaus (ARHS)<\/strong> \u2014 Telsey Advisory Group reiterated its rating of Overweight.<\/p>\n

Arlo Technologies (ARLO)<\/strong> \u2014 Piper Sandler lowered its price target to $16.00 from $18.00 and maintained its Overweight rating.<\/p>\n

ArriVent BioPharma (AVBP)<\/strong> \u2014 B. Riley Financial lowered its price target to $29.00 from $45.00 and maintained its Buy rating.<\/p>\n

Artivion (AORT)<\/strong> \u2014 Jefferies initiated at Buy with a $31.00 price target.<\/p>\n

Atlassian (TEAM)<\/strong> \u2014 BTIG Research raised its price target to $260.00 from $230.00 and maintained its Buy rating.<\/p>\n

Atlassian (TEAM)<\/strong> \u2014 Citigroup reiterated its rating of Hold.<\/p>\n

Axon Enterprise (AXON)<\/strong> \u2014 Piper Sandler lowered its price target to $561.00 from $732.00 and maintained its Overweight rating.<\/p>\n

Banco Santander (SAN)<\/strong> \u2014 Jefferies reiterated its rating of Buy ? Hold.<\/p>\n

Bancorp (TBBK)<\/strong> \u2014 DA Davidson set a price target of $64.00.<\/p>\n

Bancorp (TBBK)<\/strong> \u2014 Royal Bank Of Canada reiterated its rating of Outperform with a $60.00 price target.<\/p>\n

Baxter (BAX)<\/strong> \u2014 Wolfe Research initiated at Peer Perform.<\/p>\n

Becton Dickinson (BDX)<\/strong> \u2014 Wolfe Research initiated at Outperform.<\/p>\n

Best Buy (BBY)<\/strong> \u2014 Evercore set a price target of $95.00.<\/p>\n

Bicara Therapeutics (BCAX)<\/strong> \u2014 Morgan Stanley reiterated its rating.<\/p>\n

Biogen (BIIB)<\/strong> \u2014 Wells Fargo & Company raised its price target to $310.00 from $250.00 and maintained its Overweight rating.<\/p>\n

BioMarin Pharmaceutical (BMRN)<\/strong> \u2014 Cantor Fitzgerald reiterated its rating of Overweight with a $86.00 price target.<\/p>\n

BioMarin Pharmaceutical (BMRN)<\/strong> \u2014 JPMorgan raised its price target to $87.00 from $86.00 and maintained its Overweight rating.<\/p>\n

BlackRock (BLK)<\/strong> \u2014 TD Cowen upgraded from Hold to Buy with a $1,405.00 price target.<\/p>\n

BOK Financial (BOKF)<\/strong> \u2014 DA Davidson set a price target of $147.00.<\/p>\n

BOK Financial (BOKF)<\/strong> \u2014 Jefferies reiterated its rating of Buy with a $150.00 price target.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Melius Research set a price target of $225.00.<\/p>\n

Boston Scientific (BSX)<\/strong> \u2014 TD Cowen reiterated its rating of Neutral.<\/p>\n

Boyd Gaming (BYD)<\/strong> \u2014 JPMorgan lowered its price target to $85.00 from $93.00 and maintained its Neutral rating.<\/p>\n

Boyd Gaming (BYD)<\/strong> \u2014 Truist Financial lowered its price target to $100.00 from $110.00 and maintained its Buy rating.<\/p>\n

BP (BP)<\/strong> \u2014 DA Davidson set a price target of $49.00.<\/p>\n

BP (BP)<\/strong> \u2014 TD Cowen raised its price target to $49.00 from $47.00 and maintained its Hold rating.<\/p>\n

Braveheart Bio (BRVE)<\/strong> \u2014 Cantor Fitzgerald reiterated its rating of Overweight with a $40.00 price target.<\/p>\n

Braze (BRZE)<\/strong> \u2014 Cantor Fitzgerald downgraded its rating from Overweight to Neutral.<\/p>\n

Braze (BRZE)<\/strong> \u2014 Loop Capital downgraded its rating from Buy to Hold and set a $47.50 price target.<\/p>\n

Braze (BRZE)<\/strong> \u2014 Needham & Company LLC downgraded its rating from Buy to Hold.<\/p>\n

Braze (BRZE)<\/strong> \u2014 Oppenheimer downgraded its rating from Outperform to Market Perform.<\/p>\n

Braze (BRZE)<\/strong> \u2014 Piper Sandler downgraded its rating from Overweight to Neutral and adjusted its price target to $47.50 from $30.00.<\/p>\n

Braze (BRZE)<\/strong> \u2014 Stifel reiterated its rating of Buy ? Hold with a $47.50 price target.<\/p>\n

Braze (BRZE)<\/strong> \u2014 Wells Fargo & Company downgraded its rating from Overweight to Positive and set a $47.50 price target.<\/p>\n

Braze (BRZE)<\/strong> \u2014 William Blair downgraded its rating from Overweight to Neutral.<\/p>\n

BridgeBio Oncology Therapeutics (BBOT)<\/strong> \u2014 Oppenheimer lowered its price target to $16.00 and maintained its Outperform rating.<\/p>\n

Brightstar Lottery (BRSL)<\/strong> \u2014 Truist Financial lowered its price target to $11.00 from $13.00 and maintained its Hold rating.<\/p>\n

Camtek (CAMT)<\/strong> \u2014 B. Riley Financial lowered its price target to $166.00 from $200.00 and maintained its Buy rating.<\/p>\n

Cardinal Health (CAH)<\/strong> \u2014 Mizuho raised its price target to $280.00 from $250.00 and maintained its Outperform rating.<\/p>\n

Carter’s (CRI)<\/strong> \u2014 Needham & Company LLC reiterated its rating.<\/p>\n

Cencora (COR)<\/strong> \u2014 Argus raised its price target to $380.00 from $340.00 and maintained its Buy rating.<\/p>\n

Centrus Energy (LEU)<\/strong> \u2014 Needham & Company LLC lowered its price target to $206.00 from $262.00 and maintained its Buy rating.<\/p>\n

Centrus Energy (LEU)<\/strong> \u2014 Roth Capital set a price target of $115.00.<\/p>\n

Chemours (CC)<\/strong> \u2014 Truist Financial lowered its price target to $20.00 from $24.00 and maintained its Buy rating.<\/p>\n

Chevron (CVX)<\/strong> \u2014 The Goldman Sachs Group reiterated its rating of Buy with a $241.00 price target.<\/p>\n

Chord Energy (CHRD)<\/strong> \u2014 UBS Group raised its price target to $197.00 from $193.00 and maintained its Buy rating.<\/p>\n

Churchill Downs (CHDN)<\/strong> \u2014 JPMorgan lowered its price target to $118.00 from $123.00 and maintained its Overweight rating.<\/p>\n

Churchill Downs (CHDN)<\/strong> \u2014 Truist Financial lowered its price target to $140.00 from $145.00 and maintained its Buy rating.<\/p>\n

Citizens Financial Group (CFG)<\/strong> \u2014 Stephens lowered its price target to $65.00 from $70.00 and maintained its Equal Weight rating.<\/p>\n

Citizens Financial Group (CFG)<\/strong> \u2014 Truist Financial lowered its price target to $70.00 from $77.00 and maintained its Hold rating.<\/p>\n

Cleveland-Cliffs (CLF)<\/strong> \u2014 Morgan Stanley raised its price target to $14.00 from $12.50 and maintained its Equal Weight rating.<\/p>\n

Cleveland-Cliffs (CLF)<\/strong> \u2014 The Goldman Sachs Group reiterated its rating of Neutral with a $13.00 price target.<\/p>\n

Cleveland-Cliffs (CLF)<\/strong> \u2014 Wells Fargo & Company raised its price target to $17.00 from $14.00 and maintained its Overweight rating.<\/p>\n

Climb Bio (CLYM)<\/strong> \u2014 Deutsche Bank initiated at Buy with a $28.00 price target.<\/p>\n

Comfort Systems USA (FIX)<\/strong> \u2014 The Goldman Sachs Group set a price target of $1,875.00.<\/p>\n

Commercial Metals (CMC)<\/strong> \u2014 Barclays lowered its price target to $72.00 from $80.00 and maintained its Equal Weight rating.<\/p>\n

Concentra (CON)<\/strong> \u2014 Stephens initiated at Overweight with a $45.00 price target.<\/p>\n

ConocoPhillips (COP)<\/strong> \u2014 Susquehanna raised its price target to $175.00 from $161.00 and maintained its Positive rating.<\/p>\n

ConocoPhillips (COP)<\/strong> \u2014 The Goldman Sachs Group reiterated its rating of Buy with a $157.00 price target.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 HSBC reiterated its rating of Reduce with a $39.00 price target.<\/p>\n

Disc Medicine (IRON)<\/strong> \u2014 Morgan Stanley raised its price target to $92.00 from $90.00 and maintained its Overweight rating.<\/p>\n

Disc Medicine (IRON)<\/strong> \u2014 Wells Fargo & Company raised its price target to $124.00 from $86.00 and maintained its Overweight rating.<\/p>\n

Dominion Energy (D)<\/strong> \u2014 Mizuho lowered its price target to $67.00 from $72.00 and maintained its Neutral rating.<\/p>\n

DraftKings (DKNG)<\/strong> \u2014 JPMorgan lowered its price target to $30.00 from $33.00 and maintained its Overweight rating.<\/p>\n

DraftKings (DKNG)<\/strong> \u2014 Truist Financial lowered its price target to $26.00 from $29.00 and maintained its Buy rating.<\/p>\n

Dynex Capital (DX)<\/strong> \u2014 Keefe, Bruyette & Woods reiterated its rating of Buy ? Hold.<\/p>\n

Elanco Animal Health (ELAN)<\/strong> \u2014 Jefferies downgraded from Buy to Hold with a $24.00 price target.<\/p>\n

Eli Lilly and Company (LLY)<\/strong> \u2014 The Goldman Sachs Group reiterated its rating of Buy with a $1,413.00 price target.<\/p>\n

EMCOR Group (EME)<\/strong> \u2014 The Goldman Sachs Group lowered its price target to $795.00 from $885.00 and maintained its Neutral rating.<\/p>\n

Ensysce Biosciences (ENSC)<\/strong> \u2014 Cantor Fitzgerald initiated at Overweight with a $2.00 price target.<\/p>\n

Entegris (ENTG)<\/strong> \u2014 Citigroup reiterated its rating of Positive.<\/p>\n

EOG Resources (EOG)<\/strong> \u2014 Susquehanna raised its price target to $187.00 from $170.00 and maintained its Positive rating.<\/p>\n

Equinix (EQIX)<\/strong> \u2014 Guggenheim reiterated its rating of Buy with a $1,235.00 price target.<\/p>\n

EquipmentShare.com (EQPT)<\/strong> \u2014 Robert W. Baird lowered its price target to $28.00 from $35.00 and maintained its Outperform rating.<\/p>\n

Essential Properties Realty Trust (EPRT)<\/strong> \u2014 Barclays lowered its price target to $34.00 from $37.00 and maintained its Overweight rating.<\/p>\n

Essential Properties Realty Trust (EPRT)<\/strong> \u2014 Deutsche Bank downgraded from Buy to Hold with a $28.00 price target.<\/p>\n

Evergy (EVRG)<\/strong> \u2014 BTIG Research set a price target of $94.00.<\/p>\n

Evommune (EVMN)<\/strong> \u2014 Morgan Stanley resumed at Overweight with a $26.00 price target.<\/p>\n

Expedia Group (EXPE)<\/strong> \u2014 Melius Research set a price target of $355.00.<\/p>\n

ExxonMobil (XOM)<\/strong> \u2014 The Goldman Sachs Group reiterated its rating of Equal Weight.<\/p>\n

Eyepoint Pharmaceuticals (EYPT)<\/strong> \u2014 HC Wainwright reiterated its rating of Sector Perform.<\/p>\n

EyePoint Pharmaceuticals (EYPT)<\/strong> \u2014 JPMorgan downgraded from Neutral to Underweight.<\/p>\n

Eyepoint Pharmaceuticals (EYPT)<\/strong> \u2014 Laidlaw reiterated its rating of Buy ? Hold.<\/p>\n

EyePoint Pharmaceuticals (EYPT)<\/strong> \u2014 Mizuho downgraded from Outperform to Neutral with a $0.50 price target.<\/p>\n

Eyepoint Pharmaceuticals (EYPT)<\/strong> \u2014 Royal Bank Of Canada lowered its price target to $1.00 and maintained its Sector Perform rating.<\/p>\n

Ferrovial (FER)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft downgraded its rating from Buy to Hold.<\/p>\n

Fifth Third Bancorp (FITB)<\/strong> \u2014 Royal Bank Of Canada lowered its price target to $60.00 from $62.00 and maintained its Outperform rating.<\/p>\n

Floor & Decor (FND)<\/strong> \u2014 Jefferies lowered its price target to $47.00 from $59.00 and maintained its Hold rating.<\/p>\n

Fluence Energy (FLNC)<\/strong> \u2014 Truist Financial lowered its price target to $8.00 from $10.00 and maintained its Hold rating.<\/p>\n

Flutter Entertainment (FLUT)<\/strong> \u2014 JPMorgan lowered its price target to $110.00 from $114.00 and maintained its Neutral rating.<\/p>\n

Flutter Entertainment (FLUT)<\/strong> \u2014 Truist Financial lowered its price target to $100.00 from $120.00 and maintained its Buy rating.<\/p>\n

Fortinet (FTNT)<\/strong> \u2014 Truist Financial set a price target of $200.00 with a Buy rating.<\/p>\n

Fortrea (FTRE)<\/strong> \u2014 UBS Group raised its price target to $24.00 from $22.00 and maintained its Neutral rating.<\/p>\n

Four Corners Property Trust (FCPT)<\/strong> \u2014 Barclays lowered its price target to $25.00 from $30.00 and maintained its Equal Weight rating.<\/p>\n

FOX (FOX)<\/strong> \u2014 Citigroup reiterated its Buy rating, and $78 target.<\/p>\n

FOX (FOX)<\/strong> \u2014 Fox Advisors reiterated its rating.<\/p>\n

FOX (FOX)<\/strong> \u2014 Royal Bank Of Canada set a price target of $95.00.<\/p>\n

Freightos (CRGO)<\/strong> \u2014 Freedom Broker lowered its price target to $2.50 from $2.60 and maintained its Buy rating.<\/p>\n

Galaxy Digital (GLXY)<\/strong> \u2014 Piper Sandler lowered its price target to $25.00 from $33.00 and maintained its Overweight rating.<\/p>\n

Gaming and Leisure Properties (GLPI)<\/strong> \u2014 Barclays lowered its price target to $44.00 from $50.00 and maintained its Overweight rating.<\/p>\n

Gaming and Leisure Properties (GLPI)<\/strong> \u2014 Truist Financial lowered its price target to $55.00 from $60.00 and maintained its Buy rating.<\/p>\n

Gartner (IT)<\/strong> \u2014 Royal Bank Of Canada reiterated its rating of Sector Perform with a $198.00 price target.<\/p>\n

Gartner (IT)<\/strong> \u2014 Truist Financial raised its price target to $235.00 from $205.00 and maintained its Buy rating.<\/p>\n

Gartner (IT)<\/strong> \u2014 Wells Fargo & Company raised its price target to $175.00 from $150.00 and maintained its Underweight rating.<\/p>\n

GE Aerospace (GE)<\/strong> \u2014 Vertical Research reiterated its rating of Buy with a $400.00 price target.<\/p>\n

GE HealthCare (GEHC)<\/strong> \u2014 Wolfe Research initiated at Peer Perform.<\/p>\n

Genmab A\/S (GMAB)<\/strong> \u2014 Morgan Stanley set a price target of $42.00.<\/p>\n

Gildan Activewear (GIL)<\/strong> \u2014 Royal Bank Of Canada lowered its price target to $70.00 from $82.00 and maintained its Outperform rating.<\/p>\n

Gilead Sciences (GILD)<\/strong> \u2014 Bank of America raised its price target to $172.00 from $168.00 and maintained its Buy rating.<\/p>\n

Glass House Brands (GLAS)<\/strong> \u2014 Lake Street Capital lowered its price target to $7.00 and maintained its Buy rating.<\/p>\n

Granite Ridge Resources (GRNT)<\/strong> \u2014 Northland Securities set a price target of $11.00.<\/p>\n

H2O America (HTO)<\/strong> \u2014 BTIG Research reiterated its rating of Buy with a $65.00 price target.<\/p>\n

Healthcare Realty (HR)<\/strong> \u2014 Deutsche Bank upgraded from Hold to Buy with a $23.00 price target.<\/p>\n

Heartflow (HTFL)<\/strong> \u2014 Piper Sandler reiterated its rating of Overweight with a $64.00 price target.<\/p>\n

Heartland Express (HTLD)<\/strong> \u2014 Robert W. Baird downgraded from Outperform to Neutral with a $12.00 price target.<\/p>\n

Hershey (HSY)<\/strong> \u2014 UBS Group reiterated its rating of Overweight.<\/p>\n

Hubbell (HUBB)<\/strong> \u2014 JPMorgan resumed at Neutral with a $485.00 price target.<\/p>\n

Hut 8 (HUT)<\/strong> \u2014 Piper Sandler lowered its price target to $123.00 from $143.00 and maintained its Overweight rating.<\/p>\n

IDACORP (IDA)<\/strong> \u2014 BTIG Research set a price target of $153.00.<\/p>\n

Immix Biopharma (IMMX)<\/strong> \u2014 Morgan Stanley set a price target of $20.00.<\/p>\n

Incyte (INCY)<\/strong> \u2014 Morgan Stanley resumed at Equal-Weight with a $119.00 price target.<\/p>\n

Insmed (INSM)<\/strong> \u2014 Raymond James Financial set a price target of $173.00.<\/p>\n

Inspired Entertainment (INSE)<\/strong> \u2014 Truist Financial lowered its price target to $8.00 from $12.00 and maintained its Buy rating.<\/p>\n

Inter & Co. Inc. (INTR)<\/strong> \u2014 UBS Group raised its price target to $10.00 from $8.80 and maintained its Buy rating.<\/p>\n

Interactive Brokers Group (IBKR)<\/strong> \u2014 UBS Group set a price target of $97.00.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 Raymond James Financial set a price target of $79.00.<\/p>\n

Johnson & Johnson (JNJ)<\/strong> \u2014 TD Cowen reiterated its rating of Underweight.<\/p>\n

Kazia Therapeutics (KZIA)<\/strong> \u2014 Leerink Partners initiated at Outperform with a $30.00 price target.<\/p>\n

Kestra Medical Technologies (KMTS)<\/strong> \u2014 Evercore ISI initiated at Outperform with a $34.00 price target.<\/p>\n

Kinetik (KNTK)<\/strong> \u2014 Raymond James Financial reiterated its rating of Outperform with a $57.00 price target.<\/p>\n

Kraft Heinz (KHC)<\/strong> \u2014 JPMorgan lowered its price target to $23.00 from $24.00 and maintained its Underweight rating.<\/p>\n

Kulicke and Soffa Industries (KLIC)<\/strong> \u2014 B. Riley Financial lowered its price target to $86.00 from $105.00 and maintained its Neutral rating.<\/p>\n

Lakefront Biotherapeutics NV (LKFT)<\/strong> \u2014 Morgan Stanley resumed at Equal-Weight with a $26.00 price target.<\/p>\n

Lam Research (LRCX)<\/strong> \u2014 Evercore set a price target of $315.00.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 JPMorgan lowered its price target to $54.00 from $60.00 and maintained its Overweight rating.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 Stifel lowered its price target to $54.00 from $60.00 and maintained its Buy rating.<\/p>\n

Liberty Global (LBTYA)<\/strong> \u2014 Barclays lowered its price target to $7.00 from $10.00 and maintained its Equal Weight rating.<\/p>\n

Liberty Global (LBTYA)<\/strong> \u2014 New Street Research upgraded its rating to Buy and set a $14.00 price target.<\/p>\n

Lineage (LINE)<\/strong> \u2014 UBS Group lowered its price target to $36.00 from $45.00 and maintained its Neutral rating.<\/p>\n

Live Nation Entertainment (LYV)<\/strong> \u2014 CFRA downgraded from Hold to Sell.<\/p>\n

Live Nation Entertainment (LYV)<\/strong> \u2014 Susquehanna lowered its price target to $183.00 from $187.00 and maintained its Neutral rating.<\/p>\n

M&T Bank (MTB)<\/strong> \u2014 Truist Financial lowered its price target to $235.00 from $250.00 and maintained its Hold rating.<\/p>\n

Mach Natural Resources (MNR)<\/strong> \u2014 Northland Securities set a price target of $19.00.<\/p>\n

Manhattan Associates (MANH)<\/strong> \u2014 Citigroup reiterated its rating of Overweight.<\/p>\n

MannKind (MNKD)<\/strong> \u2014 Cantor Fitzgerald reiterated its rating of Overweight with a $8.00 price target.<\/p>\n

MARA (MARA)<\/strong> \u2014 Piper Sandler reiterated its rating of Overweight with a $11.00 price target.<\/p>\n

Marsh & McLennan Companies (MRSH)<\/strong> \u2014 JPMorgan raised its price target to $218.00 from $215.00 and maintained its Overweight rating.<\/p>\n

MaxLinear (MXL)<\/strong> \u2014 Wells Fargo & Company lowered its price target to $78.00 from $95.00 and maintained its Equal Weight rating.<\/p>\n

McDonald’s (MCD)<\/strong> \u2014 Citigroup reiterated its rating of Equal Weight.<\/p>\n

McKesson (MCK)<\/strong> \u2014 Mizuho raised its price target to $1,020.00 from $905.00 and maintained its Neutral rating.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Rosenblatt Securities reiterated its rating of Buy with a $886.00 price target.<\/p>\n

MGM Resorts International (MGM)<\/strong> \u2014 JPMorgan lowered its price target to $42.00 from $53.00 and maintained its Overweight rating.<\/p>\n

MGM Resorts International (MGM)<\/strong> \u2014 Stifel lowered its price target to $40.00 from $49.00 and maintained its Hold rating.<\/p>\n

MGM Resorts International (MGM)<\/strong> \u2014 Truist Financial lowered its price target to $45.00 from $55.00 and maintained its Buy rating.<\/p>\n

Microchip Technology (MCHP)<\/strong> \u2014 Wells Fargo & Company lowered its price target to $80.00 from $88.00 and maintained its Equal Weight rating.<\/p>\n

Microsoft (MSFT)<\/strong> \u2014 BMO Capital Markets raised its price target to $600.00 from $515.00 and maintained its Outperform rating.<\/p>\n

Microsoft (MSFT)<\/strong> \u2014 Piper Sandler reiterated its rating of Hold.<\/p>\n

Midera Food Processing (MFP)<\/strong> \u2014 William Blair initiated at Outperform.<\/p>\n

Mobia Medical (MOBI)<\/strong> \u2014 BTIG Research reiterated its rating of Buy with a $19.00 price target.<\/p>\n

Modine Manufacturing (MOD)<\/strong> \u2014 Cantor Fitzgerald initiated at Overweight with a $275.00 price target.<\/p>\n

Monolithic Power Systems (MPWR)<\/strong> \u2014 Wells Fargo & Company lowered its price target to $1,550.00 from $1,800.00 and maintained its Overweight rating.<\/p>\n

MPLX (MPLX)<\/strong> \u2014 JPMorgan resumed at Neutral with a $62.00 price target.<\/p>\n

Myriad Genetics (MYGN)<\/strong> \u2014 Piper Sandler upgraded from Underweight to Neutral with a $5.00 price target.<\/p>\n

Neostellar Capital (NSLR)<\/strong> \u2014 Barrington Research set a price target of $13.00.<\/p>\n

Newmont (NEM)<\/strong> \u2014 Citigroup reiterated its rating of Overweight.<\/p>\n

Newmont (NEM)<\/strong> \u2014 National Bank Financial lowered its price target to $135.00 from $140.00 and maintained its Sector Perform rating.<\/p>\n

News Corp. (NWSA)<\/strong> \u2014 Raymond James initiated at Outperform with a $35.00 price target.<\/p>\n

NextEra Energy (NEE)<\/strong> \u2014 BMO Capital Markets set a price target of $88.00.<\/p>\n

NextEra Energy (NEE)<\/strong> \u2014 BTIG Research reiterated its rating of Buy with a $105.00 price target.<\/p>\n

NextEra Energy (NEE)<\/strong> \u2014 Piper Sandler set a price target of $88.00.<\/p>\n

NiSource (NI)<\/strong> \u2014 JPMorgan lowered its price target to $51.00 from $52.00 and maintained its Overweight rating.<\/p>\n

NNN REIT (NNN)<\/strong> \u2014 Barclays lowered its price target to $43.00 from $47.00 and maintained its Underweight rating.<\/p>\n

Northwest Natural Gas (NWN)<\/strong> \u2014 BTIG Research set a price target of $56.00.<\/p>\n

Northwest Natural Gas (NWN)<\/strong> \u2014 Wells Fargo & Company lowered its price target to $49.00 from $50.00 and maintained its Equal Weight rating.<\/p>\n

Norwegian Cruise Line (NCLH)<\/strong> \u2014 Susquehanna lowered its price target to $16.00 from $17.00 and maintained its Neutral rating.<\/p>\n

Norwegian Cruise Line (NCLH)<\/strong> \u2014 TD Cowen lowered its price target to $20.00 from $24.00 and maintained its Buy rating.<\/p>\n

NU (NU)<\/strong> \u2014 UBS Group raised its price target to $20.50 from $18.20 and maintained its Buy rating.<\/p>\n

NuScale Power (SMR)<\/strong> \u2014 Barclays downgraded from Equal Weight to Underweight with a $5.00 price target.<\/p>\n

nVent Electric (NVT)<\/strong> \u2014 JPMorgan initiated at Overweight with a $167.00 price target.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 Wells Fargo & Company lowered its price target to $235.00 from $280.00 and maintained its Equal Weight rating.<\/p>\n

O’Reilly Automotive (ORLY)<\/strong> \u2014 Royal Bank Of Canada reiterated its rating of Outperform with a $111.00 price target.<\/p>\n

Occidental Petroleum (OXY)<\/strong> \u2014 Susquehanna raised its price target to $77.00 from $70.00 and maintained its Positive rating.<\/p>\n

Ocular Therapeutix (OCUL)<\/strong> \u2014 HC Wainwright reiterated its rating of Equal Weight.<\/p>\n

OGE Energy (OGE)<\/strong> \u2014 Wells Fargo & Company raised its price target to $49.00 from $48.00 and maintained its Equal Weight rating.<\/p>\n

Oklo (OKLO)<\/strong> \u2014 Barclays lowered its price target to $59.00 from $76.00 and maintained its Overweight rating.<\/p>\n

Olin (OLN)<\/strong> \u2014 Truist Financial lowered its price target to $15.00 from $20.00 and maintained its Hold rating.<\/p>\n

ON (ONON)<\/strong> \u2014 Jefferies reiterated its rating.<\/p>\n

ONE Gas (OGS)<\/strong> \u2014 BTIG Research set a price target of $89.00.<\/p>\n

ONEOK (OKE)<\/strong> \u2014 Raymond James Financial reiterated its rating of Outperform with a $98.00 price target.<\/p>\n

Onto Innovation (ONTO)<\/strong> \u2014 Cantor Fitzgerald reiterated its rating of Outperform.<\/p>\n

Ovintiv (OVV)<\/strong> \u2014 National Bank Financial raised its price target to $94.00 from $91.00 and maintained its Outperform rating.<\/p>\n

Palvella Therapeutics (PVLA)<\/strong> \u2014 HC Wainwright reiterated its rating of Outperform.<\/p>\n

Paylocity (PCTY)<\/strong> \u2014 Citigroup reiterated its rating of Hold ? Buy.<\/p>\n

Paylocity (PCTY)<\/strong> \u2014 Citizens Jmp raised its price target to $180.00 from $150.00 and maintained its Market Outperform rating.<\/p>\n

PENN Entertainment (PENN)<\/strong> \u2014 JPMorgan lowered its price target to $24.00 from $27.00 and maintained its Overweight rating.<\/p>\n

Permian Resources (PR)<\/strong> \u2014 Susquehanna raised its price target to $30.00 from $25.00 and maintained its Positive rating.<\/p>\n

Phreesia (PHR)<\/strong> \u2014 Citigroup reiterated its rating of Neutral.<\/p>\n

Pool (POOL)<\/strong> \u2014 Stifel lowered its price target to $175.00 from $189.00 and maintained its Hold rating.<\/p>\n

Portland General Electric (POR)<\/strong> \u2014 BTIG Research set a price target of $57.00.<\/p>\n

PPL (PPL)<\/strong> \u2014 BTIG Research reiterated its rating of Buy with a $41.00 price target.<\/p>\n

Precision Drilling (PDS)<\/strong> \u2014 TD Securities upgraded its rating from Hold to Buy.<\/p>\n

Principal Financial Group (PFG)<\/strong> \u2014 Wells Fargo & Company lowered its price target to $112.00 from $113.00 and maintained its Equal Weight rating.<\/p>\n

Private Bancorp (PBAM)<\/strong> \u2014 DA Davidson raised its price target to $107.00 from $105.00 and maintained its Buy rating.<\/p>\n

Private Bancorp (PBAM)<\/strong> \u2014 Piper Sandler raised its price target to $101.00 from $96.00 and maintained its Overweight rating.<\/p>\n

Procter & Gamble (PG)<\/strong> \u2014 Royal Bank Of Canada reiterated its rating of Outperform with a $166.00 price target.<\/p>\n

Prologis (PLD)<\/strong> \u2014 Robert W. Baird lowered its price target to $136.00 from $140.00 and maintained its Neutral rating.<\/p>\n

PTC Therapeutics (PTCT)<\/strong> \u2014 Raymond James Financial set a price target of $106.00.<\/p>\n

Public Storage (PSA)<\/strong> \u2014 Royal Bank Of Canada reiterated its rating of Sector Perform with a $318.00 price target.<\/p>\n

Range Resources (RRC)<\/strong> \u2014 Susquehanna raised its price target to $44.00 from $41.00 and maintained its Neutral rating.<\/p>\n

Rapport Therapeutics (RAPP)<\/strong> \u2014 BTIG Research raised its price target to $89.00 from $75.00 and maintained its Buy rating.<\/p>\n

Rapport Therapeutics (RAPP)<\/strong> \u2014 HC Wainwright reiterated its rating of Buy with a $66.00 price target.<\/p>\n

Rapport Therapeutics (RAPP)<\/strong> \u2014 Raymond James Financial reiterated its rating of Strong-Buy with a $86.00 price target.<\/p>\n

Rapport Therapeutics (RAPP)<\/strong> \u2014 TD Cowen reiterated its rating of Strong-Buy.<\/p>\n

Realty Income (O)<\/strong> \u2014 Barclays lowered its price target to $61.00 from $65.00 and maintained its Equal Weight rating.<\/p>\n

Red Cat (RCAT)<\/strong> \u2014 Needham & Company LLC reiterated its rating of Buy with a $15.00 price target.<\/p>\n

Red Rock Resorts (RRR)<\/strong> \u2014 JPMorgan lowered its price target to $71.00 from $72.00 and maintained its Overweight rating.<\/p>\n

Regions Financial (RF)<\/strong> \u2014 Truist Financial lowered its price target to $30.00 from $31.00 and maintained its Hold rating.<\/p>\n

RELX (RELX)<\/strong> \u2014 Citigroup downgraded from Buy to Neutral.<\/p>\n

Restaurant Brands International (QSR)<\/strong> \u2014 Citigroup reiterated its rating of Buy.<\/p>\n

Restaurant Brands International (QSR)<\/strong> \u2014 Mizuho initiated at Outperform with a $85.00 price target.<\/p>\n

RH (RH)<\/strong> \u2014 The Goldman Sachs Group lowered its price target to $140.00 from $164.00 and maintained its Neutral rating.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 JPMorgan raised its price target to $115.00 from $103.00 and maintained its Neutral rating.<\/p>\n

Rogers Communication (RCI)<\/strong> \u2014 Scotiabank reiterated its rating of Buy.<\/p>\n

Royal Caribbean Cruises (RCL)<\/strong> \u2014 Susquehanna lowered its price target to $355.00 from $372.00 and maintained its Positive rating.<\/p>\n

Royal Caribbean Cruises (RCL)<\/strong> \u2014 TD Cowen raised its price target to $340.00 from $337.00 and maintained its Buy rating.<\/p>\n

Royal Gold (RGLD)<\/strong> \u2014 TD lowered its price target to $311.00 from $315.00 and maintained its Buy rating.<\/p>\n

Rush Street Interactive (RSI)<\/strong> \u2014 JPMorgan lowered its price target to $22.00 from $30.00 and maintained its Neutral rating.<\/p>\n

Salesforce (CRM)<\/strong> \u2014 Citigroup reiterated its Hold rating, $263 target.<\/p>\n

Salesforce (CRM)<\/strong> \u2014 Evercore reiterated its Outperform rating, $290 target.<\/p>\n

Salesforce (CRM)<\/strong> \u2014 Jefferies reiterated its rating of Buy.<\/p>\n

SBA Communications (SBAC)<\/strong> \u2014 Sanford C. Bernstein lowered its price target to $208.00 from $219.00 and maintained its Market Perform rating.<\/p>\n

Schrodinger (SDGR)<\/strong> \u2014 UBS Group raised its price target to $21.00 from $19.00 and maintained its Neutral rating.<\/p>\n

Seagate Technology (STX)<\/strong> \u2014 Morgan Stanley raised its price target to $1,200.00 from $1,187.00 and maintained its Overweight rating.<\/p>\n

Sempra Energy (SRE)<\/strong> \u2014 BTIG Research set a price target of $100.00.<\/p>\n

ServiceNow (NOW)<\/strong> \u2014 Sanford C. Bernstein reiterated its rating of Outperform with a $266.00 price target.<\/p>\n

SiTime (SITM)<\/strong> \u2014 Rosenblatt initiated at Buy with a $750.00 price target.<\/p>\n

SM Energy (SM)<\/strong> \u2014 Susquehanna raised its price target to $44.00 from $32.00 and maintained its Neutral rating.<\/p>\n

Southern (SO)<\/strong> \u2014 Jefferies set a price target of $95.00.<\/p>\n

Southwest Gas (SWX)<\/strong> \u2014 JPMorgan lowered its price target to $101.00 from $102.00 and maintained its Overweight rating.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Cantor Fitzgerald reiterated its rating of Neutral.<\/p>\n

Spire (SR)<\/strong> \u2014 JPMorgan raised its price target to $86.00 from $85.00 and maintained its Neutral rating.<\/p>\n

Sportradar Group (SRAD)<\/strong> \u2014 JPMorgan lowered its price target to $13.00 from $15.00 and maintained its Neutral rating.<\/p>\n

Spotify Technology (SPOT)<\/strong> \u2014 Rosenblatt Securities reiterated its rating of Neutral with a $527.00 price target.<\/p>\n

Sprouts Farmers Market (SFM)<\/strong> \u2014 Royal Bank Of Canada lowered its price target to $111.00 from $114.00 and maintained its Outperform rating.<\/p>\n

SPS Commerce (SPSC)<\/strong> \u2014 Citigroup reiterated its rating of Neutral.<\/p>\n

Starbucks (SBUX)<\/strong> \u2014 Citigroup reiterated its rating of Neutral.<\/p>\n

Steel Dynamics (STLD)<\/strong> \u2014 The Goldman Sachs Group reiterated its rating of Buy with a $299.00 price target.<\/p>\n

Sunoco (SUN)<\/strong> \u2014 JPMorgan resumed at Overweight with a $87.00 price target.<\/p>\n

Synchrony Financial (SYF)<\/strong> \u2014 Jefferies reiterated its rating of Buy with a $103.00 price target.<\/p>\n

Synchrony Financial (SYF)<\/strong> \u2014 Royal Bank Of Canada reiterated its rating of Outperform.<\/p>\n

Synopsys (SNPS)<\/strong> \u2014 Morgan Stanley raised its price target to $574.00 from $500.00 and maintained its Overweight rating.<\/p>\n

Tapestry (TPR)<\/strong> \u2014 UBS Group lowered its price target to $200.00 from $232.00 and maintained its Buy rating.<\/p>\n

Targa Resources (TRGP)<\/strong> \u2014 Raymond James Financial reiterated its rating of Strong-Buy with a $340.00 price target.<\/p>\n

Teck Resources (TECK)<\/strong> \u2014 Stifel raised its price target to $95.00 from $82.00 and maintained its Hold rating.<\/p>\n

Tenable (TENB)<\/strong> \u2014 Truist Financial raised its price target to $35.00 from $30.00 and maintained its Hold rating.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 Cantor Fitzgerald reiterated its Hold rating, and $340 target.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 Wells Fargo & Company lowered its price target to $300.00 from $310.00 and maintained its Equal Weight rating.<\/p>\n

Thomson Reuters (TRI)<\/strong> \u2014 Jefferies initiated at Buy with a $130.00 price target.<\/p>\n

TKO Group (TKO)<\/strong> \u2014 Guggenheim lowered its price target to $228.00 from $235.00 and maintained its Buy rating.<\/p>\n

TKO Group Holdings (TKO)<\/strong> \u2014 Arete upgraded from Neutral to Buy with a $208.00 price target.<\/p>\n

Tonix Pharmaceuticals (TNXP)<\/strong> \u2014 Raymond James Financial reiterated its rating of Buy.<\/p>\n

Torrid (CURV)<\/strong> \u2014 William Blair reiterated its rating of Buy.<\/p>\n

Travelers Companies (TRV)<\/strong> \u2014 BMO Capital Markets set a price target of $388.00.<\/p>\n

Travelers Companies (TRV)<\/strong> \u2014 JPMorgan raised its price target to $379.00 from $352.00 and maintained its Neutral rating.<\/p>\n

Travelers Companies (TRV)<\/strong> \u2014 Keefe, Bruyette & Woods raised its price target to $382.00 from $372.00 and maintained its Market Perform rating.<\/p>\n

Travelers Companies (TRV)<\/strong> \u2014 Mizuho raised its price target to $371.00 from $345.00 and maintained its Neutral rating.<\/p>\n

Trex (TREX)<\/strong> \u2014 Stifel upgraded from Hold to Buy with a $55.00 price target.<\/p>\n

Trinity Industries (TRN)<\/strong> \u2014 The Goldman Sachs Group set a price target of $30.00.<\/p>\n

Tronox (TROX)<\/strong> \u2014 Truist Financial lowered its price target to $4.00 from $7.00 and maintained its Hold rating.<\/p>\n

Truist Financial (TFC)<\/strong> \u2014 Stephens lowered its price target to $54.00 from $55.00 and maintained its Overweight rating.<\/p>\n

Tvardi Therapeutics (TVRD)<\/strong> \u2014 Chardan Capital Markets initiated at Buy with a $8.00 price target.<\/p>\n

UMB Financial (UMBF)<\/strong> \u2014 Truist Financial lowered its price target to $156.00 from $170.00 and maintained its Buy rating.<\/p>\n

United Airlines (UAL)<\/strong> \u2014 Sanford C. Bernstein set a price target of $160.00.<\/p>\n

United Therapeutics (UTHR)<\/strong> \u2014 Raymond James Financial reiterated its rating of Outperform with a $717.00 price target.<\/p>\n

UnitedHealth Group (UNH)<\/strong> \u2014 Royal Bank Of Canada raised its price target to $498.00 from $478.00 and maintained its Outperform rating.<\/p>\n

Venture Global (VG)<\/strong> \u2014 Wells Fargo upgraded from Equal Weight to Overweight with a $21.00 price target.<\/p>\n

Vertiv (VRT)<\/strong> \u2014 Roth Capital reiterated its rating of Overweight.<\/p>\n

VICI Properties (VICI)<\/strong> \u2014 Barclays lowered its price target to $28.00 from $31.00 and maintained its Overweight rating.<\/p>\n

VICI Properties (VICI)<\/strong> \u2014 Truist Financial lowered its price target to $32.00 from $38.00 and maintained its Buy rating.<\/p>\n

Vicor (VICR)<\/strong> \u2014 Needham & Company LLC reiterated its rating of Buy with a $350.00 price target.<\/p>\n

Victoria’s Secret & Co. (VSXY)<\/strong> \u2014 Barclays raised its price target to $112.00 from $106.00 and maintained its Overweight rating.<\/p>\n

Viking (VIK)<\/strong> \u2014 Susquehanna lowered its price target to $100.00 from $105.00 and maintained its Positive rating.<\/p>\n

Viking Therapeutics (VKTX)<\/strong> \u2014 Canaccord Genuity Group lowered its price target to $106.00 from $114.00 and maintained its Buy rating.<\/p>\n

VinFast Auto (VFS)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to $4.00 from $5.00 and maintained its Overweight rating.<\/p>\n

Vodafone (VOD)<\/strong> \u2014 Barclays downgraded from Equal Weight to Underweight.<\/p>\n

W.P. Carey (WPC)<\/strong> \u2014 Barclays lowered its price target to $76.00 from $80.00 and maintained its Equal Weight rating.<\/p>\n

W.R. Berkley (WRB)<\/strong> \u2014 Mizuho raised its price target to $73.00 from $70.00 and maintained its Neutral rating.<\/p>\n

W.R. Berkley (WRB)<\/strong> \u2014 Wells Fargo & Company reiterated its rating of Underweight with a $68.00 price target.<\/p>\n

Wabash National (WNC)<\/strong> \u2014 National Bank Financial set a price target of $25.00.<\/p>\n

Walmart (WMT)<\/strong> \u2014 Evercore reiterated its Buy rating, raised target to $130.00 from $125.00.<\/p>\n

Wayfair (W)<\/strong> \u2014 Piper Sandler raised its price target to $135.00 from $133.00 and maintained its Overweight rating.<\/p>\n

WEC Energy Group (WEC)<\/strong> \u2014 BTIG Research set a price target of $127.00.<\/p>\n

Werner Enterprises (WERN)<\/strong> \u2014 Robert W. Baird downgraded from Outperform to Neutral with a $32.00 price target.<\/p>\n

Werner Enterprises (WERN)<\/strong> \u2014 Bank of America lowered its price target to $32.00 from $40.00 and maintained its Underperform rating.<\/p>\n

Werner Enterprises (WERN)<\/strong> \u2014 Barclays lowered its price target to $38.00 from $40.00 and maintained its Equal Weight rating.<\/p>\n

Werner Enterprises (WERN)<\/strong> \u2014 Wells Fargo & Company lowered its price target to $35.00 from $37.00 and maintained its Equal Weight rating.<\/p>\n

Western Alliance Bancorporation (WAL)<\/strong> \u2014 DA Davidson set a price target of $107.00.<\/p>\n

Western Alliance Bancorporation (WAL)<\/strong> \u2014 Piper Sandler set a price target of $96.00.<\/p>\n

Western Digital (WDC)<\/strong> \u2014 Morgan Stanley lowered its price target to $643.00 from $676.00 and maintained its Overweight rating.<\/p>\n

Western Midstream (WES)<\/strong> \u2014 JPMorgan resumed at Neutral with a $50.00 price target.<\/p>\n

Williams-Sonoma (WSM)<\/strong> \u2014 Evercore set a price target of $255.00.<\/p>\n

Williams-Sonoma (WSM)<\/strong> \u2014 Piper Sandler reiterated its rating of Overweight with a $286.00 price target.<\/p>\n

Wintrust Financial (WTFC)<\/strong> \u2014 DA Davidson set a price target of $180.00.<\/p>\n

Wynn Resorts (WYNN)<\/strong> \u2014 JPMorgan lowered its price target to $115.00 from $134.00 and maintained its Overweight rating.<\/p>\n

Wynn Resorts (WYNN)<\/strong> \u2014 Stifel lowered its price target to $120.00 from $143.00 and maintained its Buy rating.<\/p>\n

Wynn Resorts (WYNN)<\/strong> \u2014 Truist Financial lowered its price target to $110.00 from $125.00 and maintained its Buy rating.<\/p>\n

Wynn Resorts (WYNN)<\/strong> \u2014 UBS Group set a price target of $120.00.<\/p>\n

Xcel Energy (XEL)<\/strong> \u2014 BMO Capital Markets set a price target of $86.00.<\/p>\n

Xcel Energy (XEL)<\/strong> \u2014 BTIG Research reiterated its rating of Buy with a $91.00 price target.<\/p>\n

Xcel Energy (XEL)<\/strong> \u2014 Jefferies reiterated its rating of Buy with a $99.00 price target.<\/p>\n

Xcel Energy (XEL)<\/strong> \u2014 Royal Bank Of Canada set a price target of $86.00.<\/p>\n

Zenas Biopharma (ZBIO)<\/strong> \u2014 Morgan Stanley resumed at Equal-Weight with a $32.00 price target.<\/p>\n

Zions Bancorporation, N.A. (ZION)<\/strong> \u2014 DA Davidson raised its price target to $80.00 from $79.00 and maintained its Buy rating.<\/p>\n

Zions Bancorporation, N.A. (ZION)<\/strong> \u2014 JPMorgan raised its price target to $87.00 from $86.00 and maintained its Underweight rating.<\/p>\n

Zions Bancorporation, N.A. (ZION)<\/strong> \u2014 Morgan Stanley lowered its price target to $77.00 from $78.00 and maintained its Underweight rating.<\/p>\n

Zions Bancorporation, N.A. (ZION)<\/strong> \u2014 Royal Bank Of Canada reiterated its rating of Sector Perform with a $76.00 price target.<\/p>\n

Zions Bancorporation, N.A. (ZION)<\/strong> \u2014 TD Cowen reiterated its rating of Hold with a $69.00 price target.<\/p>\n

Zoetis (ZTS)<\/strong> \u2014 Jefferies downgraded from Buy to Hold with a $83.00 price target.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) The overall U.S. analyst outlook remains cautious, with 107 price target reductions significantly outnumbering 51 increases, suggesting growing concerns over stock…<\/p>\n","protected":false},"author":3,"featured_media":65037,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nUS Analyst Updates \u2014 October 20th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US Analyst Updates \u2014 October 20th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) The overall U.S. analyst outlook remains cautious, with 107 price target reductions significantly outnumbering 51 increases, suggesting growing concerns over stock…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-20T19:48:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-20T19:49:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2025\/06\/Apple-log-building.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1365\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"24 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"US Analyst Updates \u2014 October 20th, 2026\",\"datePublished\":\"2026-10-20T19:48:41+00:00\",\"dateModified\":\"2026-10-20T19:49:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/\"},\"wordCount\":4933,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/\",\"name\":\"US Analyst Updates \u2014 October 20th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-20T19:48:41+00:00\",\"dateModified\":\"2026-10-20T19:49:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"US Analyst Updates \u2014 October 20th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"US Analyst Updates \u2014 October 20th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/","og_locale":"en_US","og_type":"article","og_title":"US Analyst Updates \u2014 October 20th, 2026","og_description":"Analyst Ratings (USA) The overall U.S. analyst outlook remains cautious, with 107 price target reductions significantly outnumbering 51 increases, suggesting growing concerns over stock…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-20T19:48:41+00:00","article_modified_time":"2026-10-20T19:49:43+00:00","og_image":[{"width":2048,"height":1365,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2025\/06\/Apple-log-building.jpg","type":"image\/jpeg"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"24 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"US Analyst Updates \u2014 October 20th, 2026","datePublished":"2026-10-20T19:48:41+00:00","dateModified":"2026-10-20T19:49:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/"},"wordCount":4933,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/","name":"US Analyst Updates \u2014 October 20th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-20T19:48:41+00:00","dateModified":"2026-10-20T19:49:43+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-20th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"US Analyst Updates \u2014 October 20th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76467"}],"version-history":[{"count":5,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76467\/revisions"}],"predecessor-version":[{"id":76475,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76467\/revisions\/76475"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/65037"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}